3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
41
Observational
1
Expanded_access
1
Sponsor
Cancer Type
Gastrointestinal
6
Genitourinary
4
NET
2
Endocrine
2
Thoracic
1
Sarcoma
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Dermatologic
1
CNS
1
Conditions
Lymphoma
399
Precursor Cell Lymphoblastic Leukemia-Lymphoma
397
Leukemia, Lymphocytic, Chronic, B-Cell
215
Lymphoma, Non-Hodgkin
203
Lymphoma, Follicular
193
Lymphoma, Large B-Cell, Diffuse
180
Leukemia
164
Hodgkin Disease
160
Multiple Myeloma
118
Neoplasms
97
Leukemia, Myeloid, Acute
87
Lymphoma, Mantle-Cell
78
Burkitt Lymphoma
66
Myelodysplastic Syndromes
64
Lymphoma, B-Cell, Marginal Zone
64
Lymphoma, T-Cell, Cutaneous
62
Breast Neoplasms
62
Mycosis Fungoides
55
Recurrence
52
Lymphoma, B-Cell
50
Hematologic Neoplasms
50
Sezary Syndrome
43
Waldenstrom Macroglobulinemia
41
Myeloproliferative Disorders
39
Neoplasms, Plasma Cell
38
Lung Neoplasms
34
Lymphoma, Large-Cell, Immunoblastic
33
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
32
Leukemia, Hairy Cell
29
Lymphoma, T-Cell, Peripheral
28
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neoplasms by Histologic Type
×
Lymphoid
×
Clear all
NCT04996706
2026-05-26
LEO
Mayo Clinic
Enrolling by invitation
21,000 enrolled